Joanne F. Chou

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

Ethan Basch, Allison M. Deal, Mark G. Kris et al. · Journal of Clinical Oncology · 2015 · 2.5K citations · Full text

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

Ekaterina Doubrovina, Banu Oflaz-Sozmen, Susan E. Prockop et al. · Blood · 2011 · 416 citations · Full text

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> Mutation

Eileen M. O’Reilly, Jonathan W. Lee, Mark M. Zalupski et al. · Journal of Clinical Oncology · 2020 · 383 citations · Full text

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

Yelena Y. Janjigian, Steven B. Maron, Walid K. Chatila et al. · The Lancet Oncology · 2020 · 347 citations · Full text

First-line Pembrolizumab, Esophageal Cancer, Gastrointestinal Oncology +7

Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer

Michael I. D’Angelica, Camilo Correa‐Gallego, Philip B. Paty et al. · Annals of Surgery · 2014 · 233 citations · Full text